Collegium Pharmaceutical, Inc.
COLL
$27.72
$0.672.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 162.76M | 119.96M | 271.63M | 318.05M | 310.55M |
| Total Receivables | 228.54M | 228.46M | 183.86M | 174.69M | 179.53M |
| Inventory | 35.56M | 38.03M | 27.86M | 31.28M | 32.33M |
| Prepaid Expenses | 21.94M | 32.37M | 26.85M | 15.24M | 11.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 33.45M | 25.00M | -- | -- | 4.15M |
| Total Current Assets | 482.26M | 443.81M | 510.20M | 539.26M | 537.60M |
|
|
|||||
| Total Current Assets | 482.26M | 443.81M | 510.20M | 539.26M | 537.60M |
| Net Property, Plant & Equipment | 20.15M | 20.78M | 20.57M | 21.27M | 22.01M |
| Long-term Investments | 162.33M | 145.96M | 133.86M | 133.86M | 133.86M |
| Goodwill | 162.33M | 145.96M | 133.86M | 133.86M | 133.86M |
| Total Other Intangibles | 891.40M | 946.88M | 352.68M | 387.19M | 421.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 107.45M | 77.73M | 36.09M | 32.67M | 28.13M |
| Total Assets | 1.66B | 1.64B | 1.05B | 1.11B | 1.14B |
|
|
|||||
| Total Accounts Payable | 3.93M | 3.14M | 2.41M | 6.02M | 8.69M |
| Total Accrued Expenses | 251.55M | 244.38M | 193.36M | 162.34M | 185.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 65.85M | 65.85M | 184.37M | 184.35M | 184.32M |
| Total Finance Division Other Current Liabilities | 188.17M | 146.05M | 81.57M | 93.73M | 79.64M |
| Total Other Current Liabilities | 188.17M | 146.05M | 81.57M | 93.73M | 79.64M |
| Total Current Liabilities | 509.51M | 459.43M | 461.72M | 446.44M | 457.92M |
|
|
|||||
| Total Current Liabilities | 509.51M | 459.43M | 461.72M | 446.44M | 457.92M |
| Long-Term Debt | 908.52M | 921.44M | 369.50M | 439.79M | 483.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.54M | 5.91M | 5.59M | 5.86M | 6.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.18M | 14.10M | -- | -- | -- |
| Total Liabilities | 1.43B | 1.40B | 836.81M | 892.08M | 947.88M |
|
|
|||||
| Common Stock & APIC | 590.29M | 582.80M | 568.02M | 565.15M | 565.99M |
| Retained Earnings | -164.00M | -176.54M | -185.87M | -205.48M | -233.19M |
| Treasury Stock & Other | -197.45M | -171.99M | -165.56M | -137.51M | -137.37M |
| Total Common Equity | 228.84M | 234.28M | 216.58M | 222.17M | 195.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 228.84M | 234.28M | 216.58M | 222.17M | 195.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 228.84M | 234.28M | 216.58M | 222.17M | 195.43M |
|
|
|||||